Skip to main content

Advertisement

Log in

Reversible posterior leukoencephalopathy after combination chemotherapy

  • DIAGNOSTIC NEURORADIOLOGY
  • Published:
Neuroradiology Aims and scope Submit manuscript

Abstract

We describe a young woman with Burkitt's lymphoma, treated with intravenous adriamycine and cyclophosphamide and intrathecal cytarabine. She developed a reversible posterior leukoencephalopathy syndrome (RPLS) with typical MRI findings. Diffusion-weighted images during the first days after the onset of symptoms predicted a small irreversible lesion in the frontal lobe, verified on T2-weighted images 1 month later. The patient showed full recovery after high-dose steroid treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Received: 4 April 2000/Accepted: 17 May 2000

Rights and permissions

Reprints and permissions

About this article

Cite this article

Honkaniemi, J., Kähärä, V., Dastidar, P. et al. Reversible posterior leukoencephalopathy after combination chemotherapy. Neuroradiology 42, 895–899 (2000). https://doi.org/10.1007/s002340000482

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s002340000482

Navigation